IFNA1 and hepatitis D virus infection: The study demonstrated that the newly cloned HDV-1p and HDV3 strain strongly respond to peg-IFN-α treatment, observed by a decline in HDV viremia and intrahepatic HDV markers in mice, while a commonly used HDV-1 strain was unresponsive to IFN treatment, showing IFN resistance.